- Home
- RNR vs SNN Comparison
RNR vs SNN Comparison
Compare RNR & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNR
- SNN
- Stock Information
- Founded
- RNR 1993
- SNN 1856
- Country
- RNR Bermuda
- SNN United Kingdom
- Employees
- RNR N/A
- SNN N/A
- Industry
- RNR Property-Casualty Insurers
- SNN Industrial Specialties
- Sector
- RNR Finance
- SNN Health Care
- Exchange
- RNR Nasdaq
- SNN Nasdaq
- Market Cap
- RNR 13.4B
- SNN 11.0B
- IPO Year
- RNR 1995
- SNN 1999
- Fundamental
- Price
- RNR $257.22
- SNN $25.72
- Analyst Decision
- RNR Buy
- SNN Strong Buy
- Analyst Count
- RNR 11
- SNN 1
- Target Price
- RNR $284.00
- SNN N/A
- AVG Volume (30 Days)
- RNR 535.4K
- SNN 1.1M
- Earning Date
- RNR 01-28-2025
- SNN 02-25-2025
- Dividend Yield
- RNR 0.60%
- SNN 2.92%
- EPS Growth
- RNR 127.60
- SNN 39.77
- EPS
- RNR 69.12
- SNN 0.35
- Revenue
- RNR $12,657,306,000.00
- SNN $5,642,000,000.00
- Revenue This Year
- RNR N/A
- SNN $6.24
- Revenue Next Year
- RNR $2.45
- SNN $4.92
- P/E Ratio
- RNR $3.72
- SNN $36.51
- Revenue Growth
- RNR 58.85
- SNN 5.48
- 52 Week Low
- RNR $205.62
- SNN $23.65
- 52 Week High
- RNR $300.00
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- RNR 51.01
- SNN 62.77
- Support Level
- RNR $249.68
- SNN $23.69
- Resistance Level
- RNR $256.36
- SNN $27.10
- Average True Range (ATR)
- RNR 4.96
- SNN 0.46
- MACD
- RNR 1.56
- SNN 0.18
- Stochastic Oscillator
- RNR 76.84
- SNN 59.38
About RNR RenaissanceRe Holdings Ltd.
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.